NovartisNovartis, a Swiss drug maker, is planning to purchase a majority stake in Zhejiang Tianyuan Bio-Pharmaceutical Company, a Chinese vaccine maker. Novartis has agreed to pay $125 million for the company that holds a 3% share of China's $1 billion vaccines market. The market for vaccines is growing 20% or more in developing nations of Asia, Africa, and Australasia. In the past, vaccine use has been limited to basic shots against diseases such as polio, tuberculosis, and measles, but as the economies of these countries grow, government and private healthcare spending focuses on preventing diseases such as hepatitis B, cholera and rotavirus, tetanus, and others. Some critics are against the acquisition, claiming that prices will increase. Novartis claims it is not interested
in raising prices but rather to expand Tianyuan's product offerings.Refer to Novartis. Tianyuan has a relatively small market share of a high-growth market in China. How would this company be classified in Novartis' portfolio matrix?
A. problem child
B. star
C. cash cow
D. dog
E. emergent
Answer: A
You might also like to view...
Only large companies such as Wal-Mart, JCP, General Motors, and the Bank of America can be organized as corporations
Indicate whether the statement is true or false
Effective materials management reduces procurement, transportation, and production costs through economies of scale.
Answer the following statement true (T) or false (F)
A company sold equipment that originally cost $180,000 for $144,000 cash. The accumulated depreciation on the equipment was $36,000. The company should recognize a:
A. $36,000 loss. B. $18,000 loss. C. $0 gain or loss. D. $144,000 gain. E. $18,000 gain.
Reynaldo purchases a scooter costing $112.95. State taxes are 6% and local sales taxes are 2.6%. The store charges $25 for assembly. What is the total purchase price? (Round your answer to the nearest cent if necessary)
A) $162.88 B) $164.55 C) $147.66 D) $122.67